The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Cloud in Healthcare: Drug delivery device security.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
200+ innovations will shape the healthcare industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the healthcare industry using innovation intensity models built on over 443,000 patents, there are 200+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, software as a medical device (SaMD), AR/VR medical imaging interfaces, and automated clinical documentation are disruptive technologies that are in the early stages of application and should be tracked closely. Medical image display devices, 3d modelling and rendering, and AI-assisted EHR are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are wearable fitness monitors and medical device secure data transmission, which are now well established in the industry.
Innovation S-curve for cloud in the healthcare industry
Drug delivery device security is a key innovation area in cloud
Medical devices are becoming more linked to the Internet, hospital networks, and other medical equipment to deliver features that enhance healthcare and boost medical professionals' abilities to treat patients. The features, in turn, may also increase the potential cybersecurity vulnerabilities. Similar to computer systems, medical devices are susceptible to security flaws that might compromise their use and safety.
Drug delivery device security refers to the techniques and technologies used to stop attackers from taking control of drug delivery devices and the data they produce.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of drug delivery device security.
Key players in drug delivery device security – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to drug delivery device security
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Johnson & Johnson||97||Unlock company profile|
|DEKA Research and Development||69||Unlock company profile|
|adidas||56||Unlock company profile|
|DexCom||46||Unlock company profile|
|Fresenius & Co||45||Unlock company profile|
|Sony Group||42||Unlock company profile|
|Samsung Group||31||Unlock company profile|
|VSP Vision||31||Unlock company profile|
|Technikka Conexion||31||Unlock company profile|
|Alphabet||14||Unlock company profile|
|Pear Therapeutics||12||Unlock company profile|
|DNAnudge||11||Unlock company profile|
|POPS! Diabetes Care||8||Unlock company profile|
|CMR Surgical||7||Unlock company profile|
|ICU Medical||6||Unlock company profile|
|Panasonic||6||Unlock company profile|
|Prevayl||6||Unlock company profile|
|PharmaSecure||6||Unlock company profile|
|SoftBank Group||6||Unlock company profile|
|Qualcomm||6||Unlock company profile|
|Otsuka Holdings||6||Unlock company profile|
|Surgicalfety Technologies||6||Unlock company profile|
|West Affum Holdings||5||Unlock company profile|
|Loewenstein Medical Technology||5||Unlock company profile|
Source: GlobalData Patent Analytics
Johnson & Johnson is the leading patent filer in the drug delivery device security market. Some other leading patent filers include DEKA Research and Development and Adidas.
In terms of application diversity, Johnson & Johnson leads the pack, followed by VSP Vision and Technikka Conexion. With regards to geographic reach, DEKA Research and Development leads, followed by DNAnudge and Johnson & Johnson.
Threats and vulnerabilities are challenging to eliminate. Due to the complexity of the healthcare sector, cooperation between manufacturers, hospitals, and facilities is necessary to reduce cybersecurity risks.
To further understand how Cloud is disrupting the healthcare industry, access GlobalData’s latest thematic research report on Cloud Computing in Healthcare.